| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/03/2008 | US20080160047 Oil in water emulsions containing saponins |
| 07/03/2008 | US20080160046 Equine herpes viruses (EHV) with immunomodulatory capacity; respiratory and neurological diseases |
| 07/03/2008 | US20080160041 C-type lectin specific monoclonal antibody conjugate for use in reducing immune response to specific antigens; immunotherapy; immunosuppression; treating allergies and autoimmune diseases |
| 07/03/2008 | US20080160033 Novel Screening Method |
| 07/03/2008 | US20080160031 Method and Composition for Treatment of Neoplasms |
| 07/03/2008 | US20080160029 Treatment with anti-vegf antibodies |
| 07/03/2008 | US20080160028 Phosphodiesterase-4 (PDE-4) inhibitors; for treating bronchial asthma, COPD, rheumatoid arthritis (RA), osteoarthritis, cystic fibrosis, Guillain-Barresyndrome, Crohn's disease, ulcerative colitis, psoriasis, atopic dermatitis, allergic eczemas |
| 07/03/2008 | US20080160022 Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules |
| 07/03/2008 | US20080160019 Using mixture comprising tyrosine kinase with immunoglobulin-like and EGF-like domains-1 (TIE-1)binding agent and endothelial growth factor antagonist to treat and prevent cell proliferative disorders |
| 07/03/2008 | US20080160009 Antibodies; calcium channel modulators (mibefradil); apoptosis resistance |
| 07/03/2008 | US20080160007 Diagnosis and treatment of cancer related to human dormancy |
| 07/03/2008 | US20080160006 Nutrient broth for maintenance of brain or spinal cord tissue |
| 07/03/2008 | US20080160004 Drospirenone, ethinylestradiol; oral contraceptives; kits |
| 07/03/2008 | US20080160001 Statin mixture for use in lowering blood fat, protecting and repairing liver, kidney, heart, blood vessels and/or muscle |
| 07/03/2008 | US20080160000 Medicant mixture comprising pinene, thymol, eugenol and limonene for use in treatment of protozoal infection; antiprotozoa agents |
| 07/03/2008 | US20080159995 Using mixture comprising antifibrotic agents and stem cell modulators to treat and prevent connective tissue disorders |
| 07/03/2008 | US20080159993 Immunotherapeutic methods using epitopes of WT-1 and GATA-1 |
| 07/03/2008 | US20080159992 membrane polypeptide for use in designing therapeutic for use treatment and prevention of cell proliferative, inflammatory, skin, arthritic, cardiovascular and autoimmune disorders |
| 07/03/2008 | US20080159987 Using bifidobacteria expressing rifamycin based non-sytemic antibiotic to treat nervous system disorders; probiotics |
| 07/03/2008 | US20080159985 Matrix material comprising electrodeposited biopolymers and/or pharmeceuticals for use in transfer and release of compounds into cells |
| 07/03/2008 | US20080159984 Compositions Capable of Facilitating Penetration Across a Biological Barrier |
| 07/03/2008 | US20080159982 ethyl 2-(biphenyl-4-yl)-6-(tert-butoxycarbonylamino)-2-methoxy-8-(2-nitrophenylsulfonyl)-5,16-dioxo-1,2,3,5,6,7,10,11,13a,14,14a,15,16,16a-hexadecahydrocyclopropa[n]pyrrolo[2,1-c][1,4,8]triazacyclopentadecine-14a-carboxylate; viricide; synergistic with other active ingredients |
| 07/03/2008 | US20080159980 Glutathione s-transferase (GST); kits |
| 07/03/2008 | US20080159977 Modified, protease resistant, colony stimulating factor for use in treatment and prevention of autoimmune and cell proliferative diseases; directed protein evolution |
| 07/03/2008 | US20080159976 Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase |
| 07/03/2008 | US20080159971 Use of dhea or precursors or metabolic derivatives thereof as a depigmenting agent |
| 07/03/2008 | US20080159969 Pharmaceutical Or Cosmetic Composition Comprising Mequinol And At Least One Depigmenting Agent |
| 07/03/2008 | US20080159959 antiinflammatory agents has water-soluble N-(2-hydroxypropyl) methacrylamide copolymer linked to a glucocorticoid; drug conjugated with a polymer for targeting to bone or cartilage tissue; treatment of rheumatoid arthritis using MR imaging techniques |
| 07/03/2008 | US20080159957 administrating a non-pathogenic, insect-specific virus to induce an immune response, and effective to cause cell death in the cell; cancer vaccines and immunotherapies; immunostimulants, biodrugs |
| 07/03/2008 | US20080159955 Inhibiting the growth of tumor cells overexpressing MN protein with enzyme inhibitors of carbonic anhydrase (CA 1X) (MN protein); pyridinium derivatives of aromatic heterocyclic sulfonamides; side-effect reduction; antitumor, -carcinogenic, -metastasis agents |
| 07/03/2008 | DE112005000730T5 Ionen bindende Polymere und ihre Verwendung Ion-binding polymers and their use |
| 07/03/2008 | DE102007054788A1 Retard-Zusammensetzungen und Verfahren zu ihrer Herstellung Sustained-release compositions, and processes for their preparation |
| 07/03/2008 | DE102007054065A1 An Flavonoiden reiches Gewebe aus Neomarica gracilis und Verfahren zum Kultivieren desselben Flavonoid-rich tissue from Neomarica gracilis and method thereof for culturing |
| 07/03/2008 | DE102006062566A1 Cosmetic or dermatological topical composition, useful to treat the blemished skin and/or acne, comprises an alpha-monoalkyl glycerin ether and an active agent comprising octanediol or hexanediol in a carrier |
| 07/03/2008 | DE102006062501A1 Kosmetische und dermatologische Öl-in-Wasser-Emulsionen mit selbstkonservierenden Eigenschaften Cosmetic and dermatological oil-in-water emulsions with self-preserving properties |
| 07/03/2008 | DE102006062438A1 Cosmetic or dermatological composition, useful e.g. in the topical treatment of the skin, comprises an aporphine-alkaloids and a further active agent of e.g. purine, natural betaine compounds, monomer, oligomer or polymer of aminoacid |
| 07/03/2008 | DE102006062433A1 Deodorant or antiperspirant composition comprises a deodorant or antiperspirant agent and taurine in a carrier |
| 07/03/2008 | DE102006060707A1 Use of tertiary and quaternary aminonaphthalimide compounds in medicament for the treatment of pathogen infection, which is virus, bacterial, fungal and parasitic infection |
| 07/03/2008 | DE102006017672B4 Zusammensetzung zur Verwendung als Laxativum A composition for use as a laxative |
| 07/03/2008 | CA2707100A1 Morpholino compound microemulsion |
| 07/03/2008 | CA2674557A1 2-substituted-6-heterocyclic pyrimidone derivatives |
| 07/03/2008 | CA2674553A1 Promotion of wound contraction with a compound that promotes oestrogenic activity |
| 07/03/2008 | CA2674548A1 Novel n-(2-aminophenyl) benzamide derivative having urea structure |
| 07/03/2008 | CA2674518A1 Spiro-piperidine derivatives |
| 07/03/2008 | CA2674512A1 Amino nicotinic and isonicotinic acid derivatives as dhodh inhibitors |
| 07/03/2008 | CA2673922A1 Cycloalkylamine substituted isoquinoline and isoquinolinone derivatives |
| 07/03/2008 | CA2673921A1 Substituted isoquinolines and their use as rho-kinase inhibitors |
| 07/03/2008 | CA2673920A1 Cycloalkylamine substituted isoquinoline derivatives |
| 07/03/2008 | CA2673919A1 Cycloalkylamine substituted isoquinolone and isoquinolinone derivatives |
| 07/03/2008 | CA2673918A1 Substituted isoquinoline and isoquinolinone derivatives |
| 07/03/2008 | CA2673917A1 Cycloalkylamine substituted isoquinolone derivatives |
| 07/03/2008 | CA2673916A1 Substituted isoquinoline and isoquinolinone derivatives as inhibitors of rho-kinase |
| 07/03/2008 | CA2673736A1 Compounds and methods for kinase modulation, and indications therefor |
| 07/03/2008 | CA2673714A1 Fermented milk for skin improvement and/or treatment and process for producing the same |
| 07/03/2008 | CA2673713A1 Medicaments and methods for promoting wound contraction |
| 07/03/2008 | CA2673712A1 Medicaments and methods comprising a compound that promotes oestrogenic activity for wound healing |
| 07/03/2008 | CA2673678A1 Phosphonated glycopeptide and lipoglycopeptide antibiotics and uses thereof for the prevention and treatment of bone and joint infections |
| 07/03/2008 | CA2673647A1 Mapk/erk kinase inhibitors |
| 07/03/2008 | CA2673638A1 Medicaments and methods comprising a compound that promotes oestrogenic activity for wound healing |
| 07/03/2008 | CA2673627A1 Ciclesonide containing sterile aqueous suspension |
| 07/03/2008 | CA2673616A1 Alpha-2b adrenergic receptor agonist and serotonin-norepinephrine reuptake inhibitor compositions for treating chronic pain |
| 07/03/2008 | CA2673606A1 Alpha-2b receptor agonist and anticonvulsant compositions for treatng chronic pain |
| 07/03/2008 | CA2673601A1 Heterocyclyl-substituted-ethylamino-phenyl derivatives, their preparation and use as medicaments |
| 07/03/2008 | CA2673598A1 Macrocyclic factor viia inhibitors useful as anticoagulants |
| 07/03/2008 | CA2673522A1 Methods of immune or haematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer |
| 07/03/2008 | CA2673511A1 Pharmaceutical compositions for treatment of parkinson's disease and related disorders |
| 07/03/2008 | CA2673486A1 Substituted tetracycline compounds for treatment of inflammatory skin disorders |
| 07/03/2008 | CA2673472A1 5-cyan0-4- (pyrrolo) [2, 3b] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors |
| 07/03/2008 | CA2673466A1 Substituted tetracycline compounds |
| 07/03/2008 | CA2673410A1 Pyrrolo [3, 2-a] pyridine derivatives for inhibiting ksp kinesin activity |
| 07/03/2008 | CA2673391A1 Pharmaceutical composition using aliskiren and avosentan |
| 07/03/2008 | CA2673376A1 Protein complex and uses |
| 07/03/2008 | CA2673375A1 1-aminomethyl-l-phenyl-cyclohexane derivatives as ddp-iv inhibitors |
| 07/03/2008 | CA2673370A1 Substituted acetophenones useful as pde4 inhibitors |
| 07/03/2008 | CA2673307A1 Spiro-piperidine derivatives |
| 07/03/2008 | CA2673299A1 Pyridazinones compounds for the treatment of proliferative diseases |
| 07/03/2008 | CA2673294A1 Processes for making cyclic lipid implants for intraocular use |
| 07/03/2008 | CA2673290A1 Methods for treating obesity with a combination comprising a mtp inhibitor and a cholesterol absorption inhibitor |
| 07/03/2008 | CA2673231A1 Heterocyclic compounds with cxcr3 antagonist activity |
| 07/03/2008 | CA2673184A1 New compounds |
| 07/03/2008 | CA2673183A1 Bicyclic pyrimidinones and uses thereof |
| 07/03/2008 | CA2673070A1 Method and system for enhancing self-treatment of onychomycosis |
| 07/03/2008 | CA2673041A1 4-{4-[({3-tert-butyl-1-[3-(hydroxymethyl) phenyl]-1h-pyrazol-5-yl } carbamoyl)-amino] -3-fluorophenoxy} -n-methylpyridine-2-carboxamide as well as prodrugs and salts thereof for the treatment of cancer |
| 07/03/2008 | CA2673038A1 Substituted tricyclic heteroaryl compounds as janus kinase inhibitors |
| 07/03/2008 | CA2673022A1 Methods, compounds, and compositions for treating metabolic disorders and diabetes |
| 07/03/2008 | CA2673020A1 Spirocyclic azaadamantane derivatives and methods of use |
| 07/03/2008 | CA2673003A1 Quinazolines for pdk1 inhibition |
| 07/03/2008 | CA2673000A1 Pyrrolo [2, 3-b] pyridine derivatives as kinase modulators |
| 07/03/2008 | CA2672951A1 Hydroxy methyl phenyl pyrazolyl urea compound useful in the treatment of cancer |
| 07/03/2008 | CA2672904A1 Prostacyclin derivatives |
| 07/03/2008 | CA2672727A1 Sphingosine-1-phosphate receptor agonist and antagonist compounds |
| 07/03/2008 | CA2672718A1 Pyrimidyl derivatives as protein kinase inhibitors |
| 07/03/2008 | CA2672692A1 8-ethinylxanthine derivatives as selective a2a receptor antagonists |
| 07/03/2008 | CA2672639A1 Indol-4-yl-pyrimidinyl-2-yl-amine derivatives and use thereof as cyclin dependant kinase inhibitors |
| 07/03/2008 | CA2672564A1 Substituted heteroaryl pyridopyrimidone derivatives |
| 07/03/2008 | CA2672518A1 Organic compounds and their uses |
| 07/03/2008 | CA2672438A1 Substituted heterocycles and methods of use |
| 07/03/2008 | CA2672428A1 Abca1 elevating compounds |
| 07/03/2008 | CA2672402A1 Solid dispersion of a neurokinin antagonist |
| 07/03/2008 | CA2672213A1 New compounds |